Author
Listed:
- Obinna C. Ubah
(Elasmogen Ltd)
- Eric W. Lake
(University of Wisconsin School of Medicine and Public Health)
- Gihan S. Gunaratne
(University of Wisconsin School of Medicine and Public Health
Medical College of Wisconsin)
- Joseph P. Gallant
(University of Wisconsin School of Medicine and Public Health
University of Wisconsin School of Medicine and Public Health)
- Marie Fernie
(Elasmogen Ltd)
- Austin J. Robertson
(University of Wisconsin School of Medicine and Public Health
University of Wisconsin School of Medicine and Public Health)
- Jonathan S. Marchant
(Medical College of Wisconsin)
- Tyler D. Bold
(University of Minnesota Medical School
University of Minnesota)
- Ryan A. Langlois
(University of Minnesota
University of Minnesota)
- William E. Matchett
(University of Minnesota
University of Minnesota)
- Joshua M. Thiede
(University of Minnesota Medical School)
- Ke Shi
(University of Minnesota)
- Lulu Yin
(University of Minnesota)
- Nicholas H. Moeller
(University of Minnesota)
- Surajit Banerjee
(Cornell University, Advanced Photon Source)
- Laura Ferguson
(Elasmogen Ltd)
- Marina Kovaleva
(Elasmogen Ltd)
- Andrew J. Porter
(Elasmogen Ltd
University of Aberdeen)
- Hideki Aihara
(University of Minnesota)
- Aaron M. LeBeau
(University of Wisconsin School of Medicine and Public Health
University of Wisconsin School of Medicine and Public Health
University of Wisconsin-Madison)
- Caroline J. Barelle
(Elasmogen Ltd)
Abstract
Single-domain Variable New Antigen Receptors (VNARs) from the immune system of sharks are the smallest naturally occurring binding domains found in nature. Possessing flexible paratopes that can recognize protein motifs inaccessible to classical antibodies, VNARs have yet to be exploited for the development of SARS-CoV-2 therapeutics. Here, we detail the identification of a series of VNARs from a VNAR phage display library screened against the SARS-CoV-2 receptor binding domain (RBD). The ability of the VNARs to neutralize pseudotype and authentic live SARS-CoV-2 virus rivalled or exceeded that of full-length immunoglobulins and other single-domain antibodies. Crystallographic analysis of two VNARs found that they recognized separate epitopes on the RBD and had distinctly different mechanisms of virus neutralization unique to VNARs. Structural and biochemical data suggest that VNARs would be effective therapeutic agents against emerging SARS-CoV-2 mutants, including the Delta variant, and coronaviruses across multiple phylogenetic lineages. This study highlights the utility of VNARs as effective therapeutics against coronaviruses and may serve as a critical milestone for nearing a paradigm shift of the greater biologic landscape.
Suggested Citation
Obinna C. Ubah & Eric W. Lake & Gihan S. Gunaratne & Joseph P. Gallant & Marie Fernie & Austin J. Robertson & Jonathan S. Marchant & Tyler D. Bold & Ryan A. Langlois & William E. Matchett & Joshua M. , 2021.
"Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography,"
Nature Communications, Nature, vol. 12(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27611-y
DOI: 10.1038/s41467-021-27611-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27611-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.